Practice Tips

Bayer's Xarelto (rivaroxaban 10 mg tablets) is the second new oral anticoagulant to be marketed in Canada this year, following the introduction of Boehringer Ingelheim's Pradax (dabigatran etexilate 75 mg and 110 mg capsules) in July.

Study measures long-term effect of ACEIs in conjunction with low blood pressure goal in the treatment of African-Americans with CKD.

What’s on the minds of pharmacists across the country?

Stress take its toll if not addressed.

Leader at the forefront of pharmacy evolution in Canada.

Helping patients gain control.

Study examines effects of daily combination of folic acid, vitamin B6 and vitamin B12 on the occurrence of cardiovascular events among women with and without a history of CVD.